• The Korea Genome Conference
• /
• 2004.07a
• /
• pp.34.2-34.2
• /
• 2004

• Proceedings of the Korean Society of Life Science Conference
• /
• 2007.10a
• /
• pp.76.1-76.1
• /
• 2007

See Full Text

• Proceedings of the Korean Society of Life Science Conference
• /
• 2006.09a
• /
• pp.44.2-44.2
• /
• 2006

• Annual Conference on Human and Language Technology
• /
• 2023.10a
• /
• pp.722-725
• /
• 2023

대규모 언어 모델(LLM)은 대규모의 데이터를 학습하여 얻은 지식을 기반으로 텍스트와 다양한 콘텐츠를 인식하고 요약, 번역, 예측, 생성할 수 있는 딥러닝 알고리즘이다. 초기 공개된 LLM은 영어 기반 모델로 비영어권에서는 높은 성능을 기대할 수 없었으며, 이에 한국, 중국 등 자체적 LLM 연구개발이 활성화되고 있다. 본 논문에서는 언어가 LLM의 성능에 영향을 미치는가에 대하여 한국어 기반 LLM과 영어 기반 LLM으로 KoBEST의 4가지 Task에 대하여 성능비교를 하였다. 그 결과 한국어에 대한 사전 지식을 추가하는 것이 LLM의 성능에 영향을 미치는 것을 확인할 수 있었다.

• The Korea Genome Conference
• /
• 2002.08a
• /
• pp.36.1-36.1
• /
• 2002

• Educational Technology International
• /
• v.8 no.1
• /
• pp.1-16
• /
• 2007

The general aim of this article is to explicate what can be researched in our field based on the new understanding on the ability of human visual intelligence. To follow this aim, three key discussions were followed. The first is to explain why the human visual intelligence research is so important in our field and how it was neglected. The basic orientations of the research questions used in its framing and in answering are reviewed. After reviewing traditional research orientations, as the second discussion, alternative, more useful perspective for thinking about human visual intelligence is suggested. And the possibility of contribution for the future research in general is discussed. In doing so, human visual intelligence was defined in rather practically oriented ways rather than theoretically oriented ones. More practical perspectives were suggested. The third discussion is to show how to use the alternative perspectives of human visual intelligence in the areas of educational technology research. It was hoped that the article lays out conceptual groundwork for generation of educational technology research frameworks which can be used for the research conduct, reproduction and sharing by adopting practically oriented views on human visual intelligence as a new territory of educational technology research.

• Proceedings of the Korean Nuclear Society Conference
• /
• 2004.10a
• /
• pp.593-594
• /
• 2004

• Health Policy and Management
• /
• v.14 no.3
• /
• pp.97-121
• /
• 2004

Recently, human embryonic stem cell research raises exciting public expectation on medical possibilities as well as ethical debate. Embryo management has become an integral part of the management of infertility treatment, researches on embryo and human embryonic stem cells and so on. Britain has permitted the research on stem cells derived from human embryo which made the first nation to allow the cloning of human embryo for the stem cell research. However, new technologies such as the assisted reproductive technologies and human embryonic stem cell research continue to pose an increasing source of ethical dilemmas for physician, scientists, legislators, religious authorities and the general publics to deal with. None the less, the United Kingdom has adopted the most liberal policies regarding human embryo and human embryonic stem cell research. The implication of the British embryo management system are as follows: 1) the development of reproductive technologies and new stem cell research technologies continue to pose legal and ethical debates, since those involve several parties; 2) the UK has taken the legal and institutional approaches to cope with those serious issues; 3) the UK adopted most liberal policies regarding embryonic and human embryonic stem cell researches; 4) the British HFE Act is consistent with the existing Acts related to human embryo management and researches; 5) through amending the HFE Act to accomodate the changes of technologies, the UK try to minimize the legal and ethical burden on undertaking research regarding embryo. The debates about the researches on human embryo and human embryonic stem cells is likely to continue in the Korean society. Because of the controversy and competing ethical values, as well as the evolving technologies, so far no consensus exists in our society. It suggest that it is premature to bring closure by ruling out any particular approaches. Thus our society needs to make an efforts to find a basis which could resolve the societal controversies through enriching the societal conversation about the profound ethical issues regarding embryo management.

• Proceedings of the Korean Nuclear Society Conference
• /
• 2004.10a
• /
• pp.591-592
• /
• 2004

• The Journal of KAIRB
• /
• v.4 no.2
• /
• pp.30-35
• /
• 2022

The Human Research Protection Program (HRPP) includes all subject protection activities and entities involved in the process of planning, reviewing, and conducting clinical research and it ultimately aims that research can be conducted ethically and scientifically while protecting the rights and welfare of research subjects. At the beginning of its introduction in Korea, it was settled down by adopting the United States HRPP, especially the form of AAHRPP element and regulations. However, regulations and operating forms of HRPP have been changed according to the Korean domestic research environment. Actually, all the Korean institutions are adopted the Korean HRPP guidelines that have been officially announced by the Ministry of Food and Drug Safety in Korea. Recently, Korean domestic laws such as the "Advanced Regenerative Biology Act" or "In Vitro Diagnostic Medical Device Act" have been dramatically innovated and our research environment becomes to be more complicated. Therefore, the development of a suitable Korean HRPP model considering the Korean research environment is strongly demanded. For the early settle down of the Korean HRPP model, the positive incentive method should be applied, when the HRPP is operated and/ or properly operated. These improvements in the Korean HRPP environment will eventually lead to the appropriate protection of subjects who are participating in human clinical research and the quality improvement of clinical research.